INCOME TAXES (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
Notes Tables |
|
Schedule of Components of Income Tax Expense (Benefit) |
Components of income tax expense (benefit) were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2023 |
|
2022 |
|
2021 |
Current |
|
$ |
(140) |
|
$ |
8,476 |
|
$ |
132 |
Deferred |
|
|
18,485 |
|
|
45,184 |
|
|
(8,189) |
Total income tax expense (benefit) |
|
$ |
18,345 |
|
$ |
53,660 |
|
$ |
(8,057) |
|
Schedule of Effective Income Tax Rate Reconciliation |
The Company’s income tax expense (benefit) for 2023, 2022 and 2021 resulted in effective tax rates of 54.0%, 18.8% and (16.3)%, respectively. The reconciliation of income taxes computed at the U.S. federal statutory tax rate of 21% to these effective tax rates is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2023 |
|
2022 |
|
2021 |
Income tax expense (benefit) at the federal statutory rate |
|
$ |
7,128 |
|
$ |
59,810 |
|
$ |
(10,402) |
Compensation adjustments |
|
|
1,752 |
|
|
599 |
|
|
559 |
State income taxes |
|
|
1,143 |
|
|
2,418 |
|
|
(330) |
Valuation allowance |
|
|
8,125 |
|
|
(9,117) |
|
|
1,863 |
Other |
|
|
197 |
|
|
(50) |
|
|
253 |
Total income tax expense (benefit) |
|
$ |
18,345 |
|
$ |
53,660 |
|
$ |
(8,057) |
|
Schedule of Deferred Tax Assets and Liabilities |
|
|
|
|
|
|
|
|
|
December 31, |
|
|
2023 |
|
2022 |
Deferred tax assets: |
|
|
|
|
|
|
Derivatives |
|
$ |
8,532 |
|
$ |
25,969 |
Asset retirement obligations |
|
|
109,111 |
|
|
103,910 |
Contingent asset retirement obligations |
|
|
3,952 |
|
|
4,540 |
Right of use liability |
|
|
2,895 |
|
|
2,964 |
Federal net operating losses |
|
|
6,211 |
|
|
281 |
State net operating losses |
|
|
5,941 |
|
|
5,691 |
Interest expense limitation carryover |
|
|
17,501 |
|
|
9,620 |
Share-based compensation |
|
|
2,262 |
|
|
1,546 |
Other |
|
|
4,266 |
|
|
5,513 |
Total deferred tax asset |
|
|
160,671 |
|
|
160,034 |
Valuation allowance |
|
|
(23,202) |
|
|
(15,311) |
Total deferred tax asset after valuation allowance |
|
|
137,469 |
|
|
144,723 |
Deferred tax liabilities: |
|
|
|
|
|
|
Property and equipment |
|
$ |
92,707 |
|
$ |
80,616 |
Investment in non-consolidated entity |
|
|
2,993 |
|
|
3,951 |
Other |
|
|
3,046 |
|
|
2,948 |
Total deferred tax liabilities |
|
|
98,746 |
|
|
87,515 |
|
|
|
|
|
|
|
Net deferred tax asset |
|
$ |
38,723 |
|
$ |
57,208 |
|
Schedule of Changes to the Company's valuation allowance |
Changes to the Company’s valuation allowance are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2023 |
|
2022 |
|
2021 |
Balance at beginning of period |
|
$ |
(15,311) |
|
$ |
(24,359) |
|
$ |
(22,361) |
Additions to valuation allowance |
|
|
(7,891) |
|
|
— |
|
|
(1,998) |
Reductions to valuation allowance |
|
|
— |
|
|
9,048 |
|
|
— |
Balance at end of period |
|
$ |
(23,202) |
|
$ |
(15,311) |
|
$ |
(24,359) |
|
Summary of Operating Loss Carryforwards |
The table below presents the details of the Company’s net operating loss and interest expense limitation carryover as of December 31, 2023 (in thousands):
|
|
|
|
|
|
|
|
Amount |
|
Expiration Year |
Federal net operating loss |
|
$ |
29,578 |
|
N/A |
State net operating loss |
|
|
100,903 |
|
2026-2042 |
Interest expense limitation carryover |
|
|
79,914 |
|
N/A |
|